GENE ONLINE|News &
Opinion
Blog

Licensing
Deals Drug Discovery
HitGen Ink Deal with Cambridge Molecular to Create a Deep Learning-Driven Drug Discovery Platform
2021-11-08
Licensing Gene Writing
Tessera Therapeutics Partners with Cystic Fibrosis Foundation to Treat Life-Threatening Disease with Gene Writers
2021-11-05
Deals Gene Editing
Moderna Enters Gene Editing Market with Metagenomi Collaboration
2021-11-03
Licensing Respiratory Disease
AstraZeneca Trims Pipeline By Selling Two Respiratory Drugs to Covis Pharma
2021-11-02
Licensing CRISPR
Vertex Signs $700 Million worth CRISPR Pact with Jennifer Doudna Co-founded Gene Editing Firm
2021-10-26
Licensing RESILIENCE
Resilience, Harvard University Ink 5-Year Strategic R&D Alliance Leveraging Biomedical Innovation for a Resilient Tomorrow
2021-10-16
Licensing Gene Therapy
Takeda Inks $3.6 Billion Deal with Poseida to Advance Non-Viral Gene Therapies and Overcome Safety Issues
2021-10-13
Licensing Gene Therapy
Takeda Embarks On a Billion-Dollar Gene Therapy Deal with Selecta Biosciences
2021-10-08
Licensing Gene Therapy
Voyager Therapeutics’ Novel AAV Capsid Tech for Gene Therapy Attracts Pfizer’s Investment
2021-10-07
Licensing Cancer Immunotherapy
Xencor and Janssen Join Forces Against B-cell Lymphoma in a New Billion-Dollar Deal
2021-10-05
Licensing Mesenchymal Stem Cell
Wanting In on US Market, Cynata Taps Fujifilm to Advance Stem Cell Products
2021-10-01
Licensing cGVHD
Syndax, Incyte Sign $602 Million Collab to Advance Monoclonal Antibody
2021-09-29
Licensing mRNA
Moderna Inks Deal with AbCellera to Develop Therapeutic Antibodies for mRNA Medicines
2021-09-15
Licensing Gene Therapy
AbbVie Strikes Gene Therapy Pact with REGENXBIO to Tackle Eye Diseases
2021-09-14
Licensing RNA Editing
Eli Lilly Forays Into RNA Editing, Betting More than a Billion Dollars on ProQR’s Technology
2021-09-09
1 … 3 4 5 6 7
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top